New Ketonethiosemicarbazones for Melanogenesis Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|10|3|140-146

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.10, Iss.3, 2014-08, pp. : 140-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Let There Be Light: EpiTan’s Melanogenesis Technology Could Create New Pharmaceutical Markets

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 3, 2005-03 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite

Inhibition of RANKL: a new approach to the treatment of osteoporosis

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1097-1100

Informa Healthcare

Access to resources Recommend Favorite

Synthesis and Cholinesterase Inhibition Activity of New Pyrrolopyrimidine Derivatives

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 10, 2014-12 ,pp. : 1143-1148

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1341-1347

Bentham Science Publishers

Access to resources Recommend Favorite

A new role for GABA: inhibition of tumor cell migration

By Ortega A.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 4, 2003-04 ,pp. : 151-154

Elsevier

Access to resources Recommend Favorite